Across GLP-1 trials, about 60% of lost weight returns within a year and about 75% over the longer regain curve. Continued treatment has stronger evidence than complete withdrawal
With a long history of use in Ayurvedic and Chinese medicine, berberine has been used for infections including the herpes simplex virus, skin disorders like acne and atopic dermatitis, as well as digestive conditions
Addressing Nutrition Gaps During GLP-1/GIP Therapy Experts have increasingly highlighted the importance of addressing nutritional deficiencies and muscle health challenges associated with GLP-1/GIP therapies
Abstract We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2005 Q22024 Q3) to evaluate neurological adverse events (NAEs) associated with six glucagon-like peptide-1 receptor agonists (GLP-1 RAs): exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, and tirzepatide
Obesity should be treated like a chronic disease, and patients must continue the medication long-term to sustain the results achieved from the medication
By supporting the GPx enzyme, selenium keeps healthy levels of glutathione to guard cells